Tower Research Capital LLC (TRC) - IMMUNOCELLULAR THERAPEUTICS ownership

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 42 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 7.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q4 2015$1,0000.0%1,796
+6.8%
0.00%
Q3 2014$1,000
-50.0%
1,682
-15.3%
0.00%
Q2 2014$2,000
-66.7%
1,986
-68.8%
0.00%
-100.0%
Q4 2013$6,000
+200.0%
6,360
+653.6%
0.00%
Q3 2013$2,000
-92.3%
844
-93.6%
0.00%
-100.0%
Q2 2013$26,00013,2180.00%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q2 2014.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders